Characteristics of cancer cohorts and estimated lifetime healthcare expenditures based on TCR (July 1997–2005) and NHIRD during 10.5 years of follow-up (July 1997 to December 2007)
| Characteristics | Lung cancer | Mesothelioma | Bladder cancer | Leukaemia | ||||
| TCR | NHIRD | TCR | NHIRD | TCR | NHIRD | TCR | NHIRD | |
| Number | 51 408 | 68 926 | 136 | 428 | 12 891 | 20 128 | 5285 | 4967 |
| Age (years), mean±SD (range) | 67.7±12.0 (18–101) | 67.6±12.2 (18–103) | 60.0±14.9 (20–97) | 64.3±14.9 (22–97) | 67.6±12.6 (18–106) | 68.0±12.6 (19–105) | 53.7±19.4 (18–97) | 54.6±19.0 (18–100) |
| Median survival (month) | 8.1 | 8.3 | 6.0 | 8.2 | 93.5 | 101.1 | 12.8 | 18.7 |
| Male, % | 68.6 | 66.5 | 71.3 | 63.8 | 72.4 | 71.6 | 58.6 | 58.4 |
| Life expectancy (years) | 2.4±0.1 | 2.4±0.1 | 2.5±0.7 | 3.5±0.7 | 11.3±0.3 | 11.6±0.3 | 6.9±0.5 | 7.6±0.7 |
| EYLL | 13.7±0.1 | 13.8±0.1 | 18.9±0.7 | 15.2±0.7 | 4.7±0.3 | 4.3±0.3 | 19.4±0.5 | 18.3±0.7 |
| Lifetime healthcare expenditures (US$), mean±SE | ||||||||
| Discount 3% | ||||||||
| After cancer diagnosis | 22 359±2033 | 22 483±2094 | 14 900±2844 | 18 856±2720 | 51 987±3022 | 53 347±3363 | 59 741±4518 | 68 275±6326 |
| Included duration 3 months before diagnosis | 22 667±1971 | 22 791±2033 | 15 209±2844 | 19 165±2720 | 52 553±3098 | 53 876±3363 | 60 042±4418 | 68 577±6225 |
| Discount 5% | ||||||||
| After cancer diagnosis | 22 051±2033 | 22 236±2033 | 14 776±2535 | 18 609±2782 | 49 493±2947 | 50 778±3136 | 56 729±4016 | 65 765±4719 |
| Included duration 3 months before diagnosis | 22 359±1971 | 22 483±1971 | 15 023±2535 | 18 918±2720 | 50 022±2947 | 51 307±3136 | 57 030±4016 | 66 067±4619 |
1US$ =29.322 New Taiwan Dollar in 2010.
EYLL, expected years of life lost; NHIRD, National Health Insurance Research Database; TCR, Taiwan Cancer Registry.